Related by context. All words. (Click for frequent words.) 71 Aurora Kinase 70 5 HT2A serotonin 70 protein tyrosine phosphatase 1B 70 IAP inhibitor 70 small molecule thrombopoietin 70 Dasatinib 69 Romidepsin 69 AAG geldanamycin analog 69 CYT# potent vascular disrupting 69 CCR9 antagonist 69 neuronal nicotinic receptors NNRs 69 oral JAK1 69 5 HT2A inverse 69 Maribavir 69 vascular disrupting agents 69 Meets Primary Endpoint 69 specific lectin receptors 69 Aliskiren 69 cMET 68 Hsp# Inhibitor 68 Personalized Immunotherapy 68 Silodosin 68 Talabostat 68 Factor Receptor 68 Pathway Inhibitor 68 MKC# MT 68 Anidulafungin 68 OMP #R# 68 NS#/#A protease 68 PNP inhibitor 68 pathophysiological effects 68 Epothilones 68 novel therapeutic antibodies 68 targeting CD# 68 Initiates Phase III 68 PDE4 68 Archexin 68 Completes Patient Enrollment 68 Phase 2b Clinical Trial 68 chimeric monoclonal antibody 68 GVAX ® 68 Anti Tumor 68 Anti VEGF 68 orally administered inhibitor 68 Aflibercept 68 Epidermal Growth Factor Receptor 68 Kinase Inhibitor 68 ENMD # 68 Aviptadil 68 oral prodrug 68 A3 adenosine receptor 68 IMiDs ® 68 glucagon receptor 68 peptidic compound 67 calcitonin gene related 67 5 HT4 67 mGluR2 NAM 67 histone deacetylase HDAC inhibitors 67 Aganocide 67 HCV polymerase 67 RNA antagonists 67 novel VDA molecule 67 selectively inhibited 67 5 HT6 receptor 67 novel peptide 67 diarrhea predominant irritable 67 reversible inhibitors 67 Granulocyte Colony Stimulating Factor 67 multitargeted 67 candidate deforolimus 67 Aptamer 67 Oral Calcitonin 67 delta opioid receptor 67 Squalamine 67 Protein Kinase C 67 Interferon beta 67 Immunotherapeutic 67 Cetrorelix 67 engineered proteases 67 5 HT2A receptor 67 humanised monoclonal antibody 67 Ustekinumab 67 Sapacitabine 67 thromboxane A2 67 receptor tyrosine kinase inhibitor 67 sodium glucose cotransporter 67 Hsp# chaperone system 67 receptor modulators 67 VEGF inhibitors 67 Tyrima 67 anti secretory 67 Sphingomab 67 Histone Deacetylase 67 inhibitor COX 67 5 lipoxygenase activating 67 highly selective inhibitor 67 selective modulator 67 RANK Ligand 67 Crizotinib 67 small molecule Hedgehog 67 Fulvestrant 66 MTP inhibitor 66 Delta opioid receptor 66 anionic backbone 66 Factor VIIa 66 phosphate S1P 66 Mg Usa 66 Azacitidine 66 Maxy G# 66 proteasome inhibitor 66 PDE# inhibitors 66 SAR# [002] 66 Darinaparsin 66 Drug Candidate 66 anti amnesic 66 Monoclonal Antibody 66 Aganocide ® 66 5 HT2C 66 PDGFR 66 Initiates Enrollment 66 Letairis ambrisentan 66 PDE4 inhibitor 66 multi kinase inhibitor 66 neuronal nicotinic receptor NNR 66 Zolinza 66 JAK2 Inhibitor 66 Recombinant Human 66 Panzem R 66 Belimumab 66 Selective Inhibitor 66 mertansine 66 oral dihydropyrimidine dehydrogenase DPD 66 inverse agonist 66 JAK1 66 Bucindolol 66 Muraglitazar 66 Initiates Phase II 66 non nucleoside HCV 66 mda 7 66 Blinatumomab 66 pralatrexate injection folate analogue 66 Anthracycline 66 Topoisomerase II 66 NS5b 66 Darapladib 66 EVIZON TM 66 triggers apoptosis programmed 66 Tyrosine Kinase Inhibitor 66 nucleoside analog 66 alpha#beta# integrin 66 selective kinase inhibitor 66 Epratuzumab 66 Rigel R# 66 LymphoStat B belimumab 66 humanized therapeutic 66 norepinephrine reuptake inhibitor 66 RAF kinase 66 Elotuzumab 66 Lubiprostone 66 ATRA IV 66 TRIOLEX HE# APOPTONE HE# 66 HCV RNA polymerase 66 Temsirolimus 66 non nucleoside inhibitor 66 Orally administered 66 oral ghrelin agonist 66 polysaccharide polymer 66 Systemic Delivery 66 Initiates Dosing 66 YONDELIS 66 ARRY # 66 non porcine pancreatic 66 Phase 2a Clinical Trial 66 potent antiproliferative 66 kidney urologic 66 M2 subunit 66 Deforolimus 66 HuLuc# 66 partial agonist 66 GSK3B 66 Tasimelteon 66 GRNOPC1 contains 65 CB2 receptor selective 65 INS# [001] 65 ADP receptor antagonist 65 resolvins 65 First Patient Dosed 65 agonistic human 65 ribonucleotide reductase clinically validated 65 MAGE A3 ASCI 65 CB2 receptor 65 rivastigmine Exelon 65 γ secretase 65 selective serotonin 2C receptor 65 ropinirole Requip 65 prostanoid 65 Mg Uk 65 Antitumor Activity 65 Pegylated 65 PDGF alpha receptor 65 C5aR 65 fusion enhancers 65 certain protein tyrosine 65 Drug Shows Promise 65 Novel Oral 65 novel orally bioavailable 65 DGAT 65 prescribed proton pump 65 rxRNA 65 HuMax TAC 65 gets USFDA nod 65 Lixivaptan 65 CYP#A# CYP#D# 65 vinca alkaloid 65 Adenoviral 65 FBPase 65 Files IND 65 antiinflammatory 65 Factor VEGF 65 Initiates Clinical 65 cyclin dependent kinase inhibitor 65 cyclooxygenase COX 65 IAP inhibitors 65 chemokine receptor 65 gastro intestinal inflammation 65 interferon alpha IFN 65 Osteopontin 65 related apoptosis inducing 65 Novel Antibiotic 65 MKC# MKC# PP 65 Safinamide 65 BRAF kinase 65 Allegra fexofenadine 65 selective inhibition 65 alpha#beta# 65 TNF Tumor Necrosis Factor 65 Immunomodulatory 65 TransVax ™ 65 SYN# 65 PEGylated Fab fragment 65 peripherally acting 65 Vidaza azacitidine 65 LPA1 65 formerly LymphoStat B 65 MEK inhibitor 65 epothilone 65 IMiDs R 65 oncolytic virus therapies 65 selective androgen receptor modulator 65 ADAMTS# 65 HQK 65 Golimumab 65 TNF alpha selectively neutralizing 65 peptibody 65 Angiotensin 65 receptor partial agonist 65 novel immunomodulatory 65 Methylnaltrexone 65 metaglidasen 65 platform HDL Mimetic 65 HGS ETR2 65 histone deacetylase 65 Investigational Compound 65 Present Preclinical Data 65 Antiangiogenic 65 CYP#A# substrate 65 antiangiogenesis 65 AEG# 65 HDAC Inhibitor 65 Small Molecule 65 nicotinic acetylcholine receptor 65 Entry Inhibitor 65 inflammatory PDE 65 brain penetrant 65 therapeutic monoclonal antibody 65 JAK3 inhibitor 65 glucocorticoid receptors 65 #beta HSD 1 65 synthetic siRNA 65 Mylan Receives Approval 65 Angiotensin Converting Enzyme 65 apoptosis proteins 65 investigational monoclonal antibody 65 immune modulating 65 Elagolix 64 R#/MEM # 64 Vicriviroc 64 humanized monoclonal 64 dasatinib Sprycel 64 CysDisplay R 64 itraconazole Sporanox 64 tiapamil 64 RhuDex 64 MEK inhibitors 64 Presents Preclinical Data 64 Carcinoid tumors 64 TRPV1 agonist 64 cyclooxygenase 2 64 Aeolus Pharmaceuticals Announces 64 VEGF receptor 64 adenosine A2A 64 proteasome inhibitors 64 cytostatic 64 Tumour Vascular Disrupting Agent 64 receptor blocker 64 defensin mimetic antibiotic 64 Vascular Endothelial Growth 64 CCX# 64 secretory phospholipase A2 64 Cytomegalovirus CMV 64 anti CD3 64 Pruvel TM 64 Aplidin 64 Annamycin 64 intranasal formulation 64 MEK ERK 64 peripherally restricted 64 lysophosphatidic acid LPA 64 alefacept 64 Aurora kinase 64 LHRH antagonist 64 Piperacillin 64 Vaccine Adjuvant 64 Phase 2b Trial 64 Interferon Beta 64 Prodarsan R 64 Xcytrin R 64 Cancer Vaccines 64 JAK2 enzyme 64 Demonstrates Positive 64 OMP #M# 64 potently inhibit 64 BCG refractory carcinoma 64 LPA1 receptor 64 5 HT4 receptor 64 Iloperidone 64 Notch receptors 64 agonists antagonists 64 antisense inhibitors 64 inhibit vascular endothelial 64 microtubule inhibitor 64 nicotinic alpha 7 64 Submits Biologics License Application 64 Bicalutamide 64 Treatment Shows Promise 64 investigational humanized monoclonal antibody 64 Initiates Clinical Trial 64 Pazopanib 64 PPARg 64 Inotek Pharmaceuticals Corporation 64 reversible inhibitor 64 pan HDAC inhibitor 64 Viagra Soft Cialis Soft 64 Achieves Primary Endpoint 64 Bafetinib 64 gonadotropin releasing hormone GnRH 64 JAK3 64 selective inverse agonist 64 Initiate Phase 64 castrate resistant prostate cancer 64 Vorinostat 64 PEGylated anti 64 synthetic cannabinoid compounds 64 Long acting beta2 64 novel peptides 64 thymidylate synthase 64 small molecule tyrosine 64 cetuximab Erbitux R 64 Submits IND 64 signal transduction inhibitor 64 Leuprolide 64 LymphoStat B TM 64 Guanilib 64 Locked Nucleic Acid LNA 64 ospemifene 64 Sphingomab TM 64 SPRYCEL ® 64 Cannabinor 64 Cyclooxygenase 2 64 Ribavirin causes 64 DP VPA 64 Sudhir Agrawal D.Phil 64 antimitotic 64 Elesclomol 64 Gleevec resistant 64 prostaglandin D2 64 hedgehog pathway 64 Systemic lupus erythematosus SLE 64 epothilones 64 Galectins 64 PF # [002] 64 small molecule VR1 64 Shows Promise Against 64 developing Zerenex ferric 64 Symadex 64 B lymphocyte stimulator 64 S#P# 64 Panzem 64 Preclinical studies suggest 64 Tesetaxel 64 initiated Phase Ib 64 immuno modulatory 64 2A receptor agonist 64 small molecule glucokinase 64 Kinoid 64 D aspartate NMDA receptor 64 recurrent metastatic ovarian cancer 64 Lenocta TM sodium stibogluconate 64 mGluR5 antagonists 64 gonadotrophin releasing hormone GnRH 64 selectively inhibits 64 Combination REOLYSIN R 64 receptor inhibitor 64 MSCRAMM ® 64 Bevasiranib 64 Interferon gamma 64 Submits NDA 64 neuronal nitric oxide synthase 64 Y2 receptor 64 humanized monoclonal antibodies 64 hormone LHRH antagonist 64 Exelixis compounds 64 Romiplostim 64 #HT# 64 aurora kinase 64 proprietary polysaccharide 64 attach auristatin 64 mGluR2 positive 64 tyrosine kinase inhibitor 64 2 methoxyestradiol 64 Angiocept 64 Omacetaxine 64 PEG irinotecan 64 Onconase 64 demethylating agents 64 Novel Therapeutic 64 thalidomide Thalomid 64 inhibit platelet function 64 GRN# 64 gastrin 64 non thiazolidinedione TZD 64 Preclinical Study 64 R Saizen R 64 mGluR4 64 HSP# inhibitor 64 potent anticancer 64 Monopril 64 Presents Preclinical 64 allosteric modulator PAM 64 Tumor Necrosis Factor 64 sitaxsentan 64 Decitabine 64 tubulin inhibitor 64 delivery polymer matrix 64 Upregulation 64 Crofelemer budesonide foam 64 brand ciclesonide HFA 64 Gleevec inhibits 64 Cathepsin S 64 Bortezomib 64 histone deacetylase HDAC 64 Vandetanib 64 Valproic acid 64 Denufosol 64 SCIB1 64 Antibody Drug Conjugate 64 Schering Plough Remicade 64 Spiegelmer ® 64 Degarelix 63 Reports Preclinical Data 63 PKC# 63 imatinib Gleevec ® 63 accumulate preferentially 63 inhibit replication 63 extensively metabolized 63 Lenocta 63 potent anti angiogenic 63 targeted radiotherapeutic 63 p# MAP kinase 63 TLR9 agonists 63 M# rationally 63 Smac mimetics 63 levocetirizine 63 Receives Approvable Letter 63 Glucocorticoid 63 CORT # 63 5 HT2A 63 Launches Generic Version 63 Interferon alpha 63 HER1 63 endothelin receptor 63 5 HT1A 63 RAS MAPK pathway 63 cardio metabolic diseases 63 Enzastaurin 63 immune modulator 63 Nanobody ® 63 acetonide FA 63 alpha 2A 63 MT#/MEDI-# 63 constipation predominant irritable bowel 63 PI3K/mTOR 63 selectively inhibit 63 DXL# 63 Trastuzumab DM1 63 Nanobody 63 biologic therapeutics 63 HGS ETR1 mapatumumab 63 enhance ApoA 63 VEGFR2 inhibitor 63 Janus kinase 63 cytotoxic T lymphocyte 63 cosmetic cosmeceutical products 63 Sym# 63 non peptidic protease 63 Antithrombin 63 SGLT Inhibitors 63 Myolimus 63 SinuNase ™ 63 oral Janus kinase 63 blood clot dissolving 63 dihydrofolate reductase 63 HCV protease inhibitors 63 receptor inhibiting monoclonal 63 poly ADP ribose polymerase 63 TNFα 63 drug conjugates ADCs 63 HDAC2 63 Cethrin R 63 #beta HSD1 63 Androgen Receptor 63 HIF biology 63 Mimetics 63 Refractory Hodgkin Lymphoma 63 Benign Prostatic Hyperplasia 63 selective androgen receptor modulators 63 IL# PE#QQR 63 Randomized Phase 63 virus HCV protease inhibitor 63 Solazed TM 63 Traficet EN 63 Nucleoside 63 acetylcholinesterase 63 RANK ligand 63 myelofibrosis polycythemia vera 63 adrenergic regulation 63 Phase 2a Trial 63 Ep CAM 63 Fluvastatin 63 Chemotherapeutic 63 Aciphex R 63 Luteinizing Hormone Releasing Hormone 63 BZL# 63 thiazolides 63 small molecule defensin 63 antiproliferative effects 63 oral dual endothelin 63 Treg cell 63 enkephalin 63 Tß4 63 thrombin receptor 63 systemic juvenile idiopathic 63 hypereosinophilic syndrome 63 SNT MC# 63 Leukemias 63 PLX MS 63 sertraline Zoloft 63 mTOR mammalian target 63 selective orally bioavailable 63 Eltrombopag 63 DNA methyltransferase inhibitors 63 dopamine D2 63 AKT inhibitor 63 orally bioavailable 63 tubulin binding 63 ESBA# 63 Akt inhibitor 63 candidate REP# 63 NTDDS 63 Tocilizumab 63 folate analogue metabolic 63 Angiolix R 63 Eg5 63 Pivotal Phase 63 RhuDex R 63 inhibit EGFR 63 Complicated Skin 63 echinocandins 63 Pimavanserin 63 R sorafenib tablets 63 serotonin reuptake 63 opioid receptor antagonist 63 chronic eosinophilic leukemia 63 class mGluR5 inhibitor 63 multiple sclerosis psoriasis 63 activate SIRT1 63 small molecule agonists 63 Initiate Clinical Trial 63 Angiotensin II 63 Histone deacetylase 63 R lenalidomide 63 phosphodiesterase inhibitors 63 Avanafil 63 Cutaneous T 63 Prolactin 63 oral picoplatin 63 Clinical Trial Results 63 JAK inhibitors 63 Completes Dosing 63 CD# CEA 63 Survivin 63 bortezomib Velcade 63 Prolongs Survival 63 Neuropeptide Y 63 Gefitinib 63 SERMs 63 generation antisense inhibitor 63 protein kinase inhibitor 63 Drug Fails 63 cortisol synthesis 63 vanilloid receptor 63 endoplasmic reticulum stress 63 Raf kinase 63 chemopreventive agent 63 orally inhaled migraine 63 novel tubulin binding 63 insomnia migraine headaches 63 5 HT1A receptor 63 Cholesterol Lowering Drug 63 melanocortin receptor 63 investigational therapies 63 JAK2 inhibitor 63 neurotrophic 63 ATL# [002] 63 AVAPRO 63 TrkA 63 Daclizumab 63 relapsed leukemia 63 Cotara ® 63 PTP 1B 63 Ad5FGF 4 63 Angiotensin converting enzyme ACE 63 hormone gastrin 63 alpha folate receptor 63 Adenosine A2A 63 oral immunomodulatory 63 Genentech Rituxan 63 HuMax EGFr 63 neuro inflammatory 63 generation purine nucleoside 63 lamotrigine Lamictal 63 Receptors GPCRs 63 P#X# 63 R memantine HCl 63 Ixabepilone 63 cathepsin K inhibitor 63 CDK inhibitor 63 GPR# [002] 63 vWF 63 CU NP 63 5 HT3 antagonist 63 octreotide acetate 63 induced macular edema 63 Zalypsis 63 demonstrated anti amnesic 63 TÎ ² 4 63 NS5B polymerase 63 Platelet Derived Growth 63 Ii protein 63 oral ferric iron 63 vinorelbine tartrate 63 HCV NS5B polymerase 63 G Protein Coupled 63 Retinoic Acid 63 Dapagliflozin 63 taxane derivative 63 Interferons 63 Atripla combines 63 midstage clinical 63 Darusentan 63 Vidofludimus 63 Olaparib 63 nucleotide analogs 63 Rheumatoid Arthritis Drug 63 NS5A 63 muscarinic 63 HDAC enzymes 63 RNAi Therapeutics 63 Fovea Pharmaceuticals subsidiary 63 mGluR2 63 Novolimus 63 Nalmefene 63 vidofludimus 63 Ramoplanin 63 endogenous ligands 63 ADCC enhanced 63 Commonly prescribed 63 Hedgehog Pathway Inhibitor 63 #ME# 63 DFMO 63 antiviral antibacterial 63 Receptor Agonist 63 FUSILEV enhances 63 Bosutinib 63 siRNA therapeutics 63 inhibitor PPI 63 NPC 1C 63 cyclin dependent kinases 63 IgG1 monoclonal antibody 63 therapeutic monoclonal antibodies 63 Mipomersen 63 phosphodiesterase inhibitor 63 LHRH receptor positive 63 IMiDs ® compound 63 Ecallantide 63 purinergic receptors P#X# 63 potent cytotoxic 63 huC# DM4 63 Venlafaxine 63 MCSP respectively 62 Vitrasert R 62 TRO# 62 Licenses Novel 62 novel synthetic PEGylated 62 Roche Actemra 62 Antitumor 62 novel orally administered 62 Therapeutic Vaccine 62 CCR1 62 anti atherothrombotic 62 evaluating satraplatin 62 adrenoceptor 62 prostaglandin synthesis 62 Nitazoxanide 62 selective A2A adenosine receptor 62 Blood Pressure Drug 62 Patent Covering 62 Pancreate 62 oral isotype selective HDAC 62 Chemokine Receptor 62 endosomal release 62 selective estrogen receptor 62 ONCONASE R 62 Oral Formulation 62 delta gamma agonist 62 Prilosec omeprazole 62 tubulin polymerization 62 Aldosterone 62 PRN FDA Approves 62 Ridaforolimus 62 POTELLIGENT ® Technology 62 reverse transcriptase inhibitors 62 JAK Inhibitor 62 oral nucleoside analogue 62 Pivotal Phase III 62 Zarnestra 62 Alfacell proprietary ribonuclease 62 selective estrogen receptor modulator 62 inhibit VEGF 62 Pegloticase 62 Pagoclone 62 nucleoside analogues 62 isoform selective 62 dihydrochloride Tablets 62 treating neuropathic pain 62 Flt3 62 anti angiogenic agent 62 antifibrotic 62 c Raf kinase 62 developing Bicifadine serotonin 62 Aflibercept VEGF Trap 62 Janus Kinase 62 TRAIL receptor antibodies 62 including eniluracil ADH 62 Etanercept 62 VA# [002] 62 infectious diseases autoimmune diseases 62 MGd 62 MEK Inhibitor 62 Cancer Cachexia 62 Locked Nucleic Acid 62 tetracycline antibiotic 62 Develop Novel 62 interleukin IL -# 62 Ocrelizumab 62 CDP# 62 Earns Milestone Payment 62 RNAi therapeutic targeting PCSK9 62 AKT1 62 novel histone deacetylase 62 TKB# 62 4 PDE4 enzyme 62 Autoimmune Disorders 62 selective immunoproteasome inhibitor 62 Allosteric 62 Cyclosporin 62 novel topoisomerase 62 reuptake inhibitor 62 biased ligand 62 Arranon 62 tyrosine kinase inhibitor TKI 62 Cardiotoxicity 62 candidates Azedra TM 62 COX enzymes 62 anticancer therapeutics 62 TELINTRA 62 Granted Orphan Drug 62 Bazedoxifene 62 acyclovir Lauriad R 62 aldehyde dehydrogenase ALDH2 deficiency 62 dimebon latrepirdine 62 Alzheimer disease cognitive impairment 62 Monoclonal Antibodies 62 ELADUR ™ 62 Receives Orphan Drug Designation 62 TTR gene 62 p# MAPK 62 XL# anticancer compounds 62 resistin 62 Myelodysplastic Syndrome MDS 62 Laquinimod 62 inhibit metastasis 62 androgen receptor AR 62 heparanase 62 immunomodulator 62 NMDA antagonists 62 ErbB3 HER3 62 phase III isavuconazole 62 RhuDex ® 62 Oral Fingolimod 62 specifically hypoactive sexual 62 hypoxia activated prodrug 62 mTOR inhibition 62 immunotoxin 62 somatostatin 62 Liprotamase 62 Innate Immune 62 Miacalcin 62 ENaC 62 Zorbtive TM 62 THR beta agonist 62 Crizotinib PF # 62 imexon 62 phenothiazines 62 Therapeutic Competitors Companies 62 pharmacokinetic interactions 62 VitiGam 62 ligand TRAIL 62 hypoxia inducible factor 62 neuroprotective properties 62 Merck OSI Pharmaceuticals 62 Hormone Refractory Prostate Cancer 62 luteinizing hormone releasing 62 immunomodulating 62 methylnaltrexone bromide 62 ZOLINZA 62 verteporfin 62 PI3K inhibitor 62 Ganciclovir 62 Preclinical Evaluation 62 Vaccine Adjuvants 62 CYP#A# isoenzyme 62 Empatic ™ 62 Begins Dosing 62 Panzem R NCD 62 VEGF vascular endothelial 62 Curaxin 62 FOLOTYN ® 62 Smac mimetic 62 EP #R 62 Tezampanel 62 Cytotoxic 62 TRAIL induced apoptosis 62 BLyS specific 62 Belerofon 62 antiangiogenic 62 OMNARIS HFA 62 baminercept 62 Receives Orphan Drug 62 Dupuytren Disease 62 elotuzumab 62 Androxal TM 62 Pertuzumab 62 Novel Mechanism 62 Dalbavancin 62 Anticancer Agent 62 CCR2 62 XP# XP# 62 Fondaparinux 62 histone deacetylase HDAC inhibitor 62 HuMax CD# 62 alvespimycin 62 GW# [003] 62 Biogen Genentech 62 Tanespimycin 62 5alpha reductase 62 Previously Treated 62 Alnylam RNAi 62 Disease IBD 62 BRAF mutant 62 triggers apoptosis 62 Factor NGF 62 ALTROPANE R 62 glycogen synthase kinase 62 ASONEP TM 62 Cyclooxygenase Inhibiting Nitric Oxide 62 monoclonal antibody IgG1 Mab 62 immunomodulatory 62 incyclinide 62 Cyclin E 62 5 HT2C receptor 62 Fluconazole 62 negative allosteric modulator 62 HIV treatments Reyataz 62 agonist compounds 62 cyclin dependent kinase CDK 62 C1 INH deficiency 62 DG# compounds targeting 62 ALS #-# 62 Pafuramidine 62 Lung Cancer Drug 62 product AMD# 62 immunomodulatory properties 62 FLT3 62 ALK inhibitors 62 thetreatment 62 RON Notch 62 Fc fusion protein 62 CRF1 receptor 62 #HT#A 62 Valdoxan 62 DPP4 62 MKC# 62 Naproxcinod 62 glucocorticoid receptor 62 IMA# 62 Namenda Memantine HCl 62 anti CD3 antibody 62 GeneICE 62 Antisense 62 Peroxisome Proliferator Activated Receptor 62 product candidate Lpathomab 62 osteoclast activity 62 cromolyn sodium 62 norepinephrine reuptake inhibitor SNRI 62 Imatinib mesylate 62 antiangiogenesis therapies 62 Zoraxel 62 lintuzumab SGN 62 TLR9 agonist 62 potent suppressor 62 RNAi Therapeutic 62 oral kinase inhibitor 62 GnT 4a 62 gefitinib Iressa 62 Epilepsy Drug 62 ASONEP ™ 62 demonstrated antitumor activity 62 receptor monoclonal antibody 62 ZFP Therapeutics 62 DHFR 62 immunotherapeutics 62 PI3K/Akt pathway 62 inhibitor rofecoxib 62 CNS Disorders 62 selective antagonist 62 neurokinin 1 62 Voreloxin 62 antagomirs 62 Wnt signaling pathway 62 soluble tumor necrosis 62 monocytes macrophages 62 CRTH2 62 sulfonylhydrazine class 62 corticosteroid dexamethasone 62 sulindac 62 Cathepsin B 62 Transported Prodrug 62 Th1 type 62 Recombinant Protein 62 Milestone Payment From 62 delivers fluocinolone acetonide FA 62 guanfacine extended release 62 GGTase 62 T#I [002] 62 bexarotene 62 IMC #B 62 IL-#/# 62 Demonstrated Significant 62 PPAR peroxisome proliferator activated 62 HER2 ErbB2 62 Bicifadine 62 Cytotoxic T 62 angiogenesis inhibitor 62 COX2 62 Gamma secretase 62 NEUGENE 62 Signaling Pathway 62 Actonel risedronate